RGEN Stock Price Chart
RGEN Financial
Repligen Corp
$123.46
-2.34%
$-2.97
At close: May 08, 16:00:00 GMT-4
$123.6
0.11%
$0.14
Post-market: May 08, 20:00:00 GMT-4
Back
Repligen Corp (RGEN) Financial
Key Stats
Prev.Close
$126.43
Open
$125.83
Day's Range
$121.26 - $126.83
52 week range
$109.5 - $175.77
Volume
924.2K
Avg.Volume
829.1K
Dividend yield
--
EPS (TTM)
0.86
Market Cap
$6.9B
What is RGEN?
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,000 full-time employees. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.
